Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Colorado, Denver
M.D. Anderson Cancer Center
Hackensack Meridian Health
Celgene
H. Lee Moffitt Cancer Center and Research Institute
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Medical College of Wisconsin
Acerta Pharma BV
National Cancer Institute (NCI)
Thomas Jefferson University
Dana-Farber Cancer Institute
Takeda
University of Miami
University of Nebraska
Gilead Sciences
University of California, Irvine
University of Washington
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Bristol-Myers Squibb
Mayo Clinic
Eli Lilly and Company
Dana-Farber Cancer Institute